Intellectual Property Rights
World Intellectual Property Organization (WIPO)
KEI has permanent observer status for the World Intellectual Property Organization (WIPO), and has attended every SCCR meeting beginning in 2003, and monitors several other committees. KEI played a key role in the negotiations on the Marrakesh treaty for persons… Continue Reading
KEI Work on CRISPR and CRISPR-related Inventions
You also can search for our most recent work on clustered regularly interspaced short palindromic repeats (CRISPR) technologies using our tags here, or via our general search engine here. KEI Events regarding CRISPR 2019: Expert Workshop at Brocher Foundation- An… Continue Reading
KEI Publications
KEI publishes research and commentary in a variety of journals, periodicals, books and other independent publishing platforms. In-house, KEI presents information in blogs, correspondence and reports, as well as in occasional KEI research notes and papers. Timelines (several) Timelines regarding… Continue Reading
KEI comments at July 25, 2017 civil society stakeholder forum at the 19th round of the RCEP negotiation
These are the notes I used when providing the KEI comments at the July 25, 2017 civil society stakeholder forum at the 19th round of the RCEP negotiation.
My name is James Love. I work for Knowledge Ecology International, an NGO that focuses on the social aspects to the production, management and control of knowledge goods. I am also a member of the board of directors of the Union for Affordable Cancer Treatment.
The IP Chapter is complex, and in the time allocated, I will discuss five issues.
German Federal Supreme Court Affirms Compulsory License on HIV Drug
On July 11, 2017, the German Federal Supreme Court announced that it had affirmed the decision of the Federal Patent Court last year to issue a compulsory license allowing Merck to continue selling its HIV drug, raltegravir (marketed as Isentress).
WIPO SCP 26 KEI Side Event: Running royalties as remedy to continued infringement of patents, with an emphasis on United States
Today at WIPO, KEI hosted a side event to discuss the ability of countries to deny injunctions in patent infringement cases.
SCP26: Statement of Knowledge Ecology International on Patents and Health (July 4th, 2017)
On July 4th, 2017, Andrew Goldman delivered Knowledge Ecology International’s intervention on patents at health at the 26th session of the WIPO Standing Committee on the Law of Patents (SCP).
KEI Statement on Patents and Health
WIPO Standing Committee on the Law of Patents – 26th SessionJuly 4th, 2017
Since the African Group and Development Agenda Group first tabled their proposal on a work program on patents and health in May 2011, much has happened.
Save The Date – 5 July 2017 – KEI side event @ WIPO SCP 26 – Compulsory licensing of patents in the United States
Knowledge Ecology International: Compulsory licensing of patents in the United States
DATE: Wednesday, 5 July 2017
TIME: 1 PM to 3 PM
VENUE: Room NB0.107, World Intellectual Property Organization
Knowledge Ecology International (KEI) cordially invites you to attend our side event during deliberations at the Twenty-Sixth Session of Standing Committee on the Law of Patents (SCP) of the World Intellectual Property Organization (WIPO).
June 2017 – WTO TRIPS Council – Statement of India on IP and the Public Interest – Compulsory Licensing
As reported by Knowledge Ecology International (KEI), on 6 June 2017, the World Trade Organization (WTO), published a paper tabled by Brazil, China, Fiji, India, and South Africa entitled, “Intellectual Property and the Public Interest.” In their communication (IP/C/W/630), the proponents called for a series of discussions at the WTO TRIPS Council on Intellectual Property and the Public Interest. Continue Reading